Emerald Cloud Lab vs ConcertAI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Emerald Cloud Lab offers a fully remote, cloud-controlled laboratory with 200+ instrument models; ~$15M ARR as of 2025 with labs in the U.S. and expanded facilities in Austin and Pittsburgh.
About
Emerald Cloud Lab (ECL) is a biotechnology infrastructure company that enables scientists to conduct real wet-lab experiments entirely remotely through a cloud-based interface. Founded as a spin-out of Emerald Therapeutics, ECL operates physical laboratories stocked with over 200 instrument models — including liquid handlers, mass spectrometers, and genomics tools — that researchers control through its unified Command Center software. Scientists can design, execute, and analyze experiments without ever entering a physical lab, democratizing access to advanced instrumentation that would otherwise require millions in capital expenditure.
ConcertAI is an oncology AI and real-world data company at a $1.9B valuation — 5.5M multi-modal cancer RWD records, $230M+ raised, exiting FY2024 profitable with mid-teens EBITDA margins.
About
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates multi-modal patient data — including electronic health records, genomics, imaging, and pathology — from a network of oncology providers to support biopharma companies in clinical trial design, site selection, protocol optimization, patient matching, and regulatory submission.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.